How has surgery developed over the last decade?

Is lung cancer screening ready for implementation in Europe?

What is the potential for using monoclonal antibodies in multiple myeloma?

Surgery in synchronous oligometastatic disease

Results of a placebo­ controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer

Brain metastases genomic analysis could reveal new targets for treatment

Examining NSCLC responses to durvalumab monotherapy

Watchful waiting versus neck dissection in patients with head and neck cancers

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer

Genetic screening of brain metastases could reveal new targets for treatment

Comment: New immunotherapy options for kidney cancer

Cytogenetic and proteomic prognostic markers of CLL